Qianjin Pharmaceutical’s Stock Soars 43% on New Policy Boost in Innovative Drugs
Zhuzhou Qianjin Pharmaceutical surges as China’s new insurance policy boosts innovation‑drug stocks, driving growth in traditional medicine‑based pharma.
2 minutes to read